MENU
+Compare
TLSA
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$1.69
Change
-$0.10 (-5.59%)
Capitalization
200.81M

TLSA Tiziana Life Sciences Ltd Forecast, Technical & Fundamental Analysis

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases... Show more

Industry: #Biotechnology
TLSA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TLSA with price predictions
Nov 28, 2025

TLSA's Stochastic Oscillator sits in overbought zone for 2 days

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

TLSA moved below its 50-day moving average on November 03, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TLSA crossed bearishly below the 50-day moving average on November 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TLSA entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 25, 2025. You may want to consider a long position or call options on TLSA as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TLSA just turned positive on November 25, 2025. Looking at past instances where TLSA's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

TLSA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TLSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.834) is normal, around the industry mean (27.312). P/E Ratio (0.000) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (321.020).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
TLSA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Church Street
Phone
+44 207 495-2379
Employees
9
Web
https://www.tizianalifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSDOF18.19N/A
N/A
Shiseido Company, Ltd.
FPRGF0.32N/A
N/A
Falco Resources Ltd.
FUJSF18.27N/A
N/A
Fuji Seal, Inc.
NRVTF0.08N/A
N/A
NORAM LITHIUM CORP
HRSHF3.35N/A
N/A
HAIER SMART HOME CO LTD.

TLSA and Stocks

Correlation & Price change

A.I.dvisor tells us that TLSA and ADTX have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLSA and ADTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLSA
1D Price
Change %
TLSA100%
N/A
ADTX - TLSA
24%
Poorly correlated
-11.75%
AGIO - TLSA
23%
Poorly correlated
-3.05%
ARVN - TLSA
22%
Poorly correlated
-1.27%
DARE - TLSA
22%
Poorly correlated
+2.40%
CRBU - TLSA
22%
Poorly correlated
-0.56%
More